Cargando…

Effects of miR-338 on morphine tolerance by targeting CXCR4 in a rat model of bone cancer pain

The present study aimed to investigate the effects of miR-338 on morphine tolerance through the targeting of CXC chemokine receptor-4 (CXCR4) in a rat model of bone cancer pain (BCP). Sprague–Dawley (SD) rats were obtained and divided into model saline (n=10), model morphine (n=50), normal saline (n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Hong-Xia, Zhou, Min-Hong, Zhang, Xing-Wang, Huang, Xi-Xi, Wang, Yong-Le, Wang, Pei-Fang, Zhan, Gong-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350600/ https://www.ncbi.nlm.nih.gov/pubmed/28108674 http://dx.doi.org/10.1042/BSR20160517

Ejemplares similares

Effects of miR-219/miR-338 on microglia and astrocyte behaviors and astrocyte-oligodendrocyte precursor cell interactions
por: Nguyen, Lan Huong, et al.
Publicado: (2019)

miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats
por: Wang, Jian, et al.
Publicado: (2016)

miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5
por: Zhang, Xiaoqian, et al.
Publicado: (2017)

Molecular interactions of miR-338 during tumor progression and metastasis
por: Moghbeli, Meysam
Publicado: (2021)

MiR-338-3p improved lung adenocarcinoma by AKAP12 suppression
por: Chang, Jin, et al.
Publicado: (2019)

miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B
por: Sun, Feng, et al.
Publicado: (2018)

Effects of Electroacupuncture Treatment on Bone Cancer Pain Model with Morphine Tolerance
por: Sima, Lei, et al.
Publicado: (2016)

69742 miR-338-5p as a Biomarker of Neuropathic Pain After Spinal Cord Injury
por: Kowalski, Jesse, et al.
Publicado: (2021)

miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3
por: Wang, Li, et al.
Publicado: (2019)

miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats
por: Wang, Jian, et al.
Publicado: (2017)

Overexpression of GDNF in Spinal Cord Attenuates Morphine Analgesic Tolerance in Rats with Bone Cancer Pain
por: Xu, Wei, et al.
Publicado: (2022)

miR-873a-5p Targets A20 to Facilitate Morphine Tolerance in Mice
por: Huang, Jiangju, et al.
Publicado: (2019)

Co-Administration of nalbuphine to improve morphine tolerance in mice with bone cancer pain
por: Ren, Bingxu, et al.
Publicado: (2023)

Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2015)

Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4
por: Duan, Xin, et al.
Publicado: (2019)

Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain
por: Liu, Lei, et al.
Publicado: (2017)

The hsa_circ_0039857/miR-338-3p/RAB32 axis promotes the malignant progression of colorectal cancer
por: Xu, Pei, et al.
Publicado: (2022)

MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation
por: Howe, James R., et al.
Publicado: (2017)

miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
por: Chen, Jing-Song, et al.
Publicado: (2016)

Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP
por: Li, Pu, et al.
Publicado: (2013)

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis
por: Liang, Yingchun, et al.
Publicado: (2017)

Arbutin suppresses osteosarcoma progression via miR‐338‐3p/MTHFD1L and inactivation of the AKT/mTOR pathway
por: Wang, Cheng‐Qun, et al.
Publicado: (2020)

Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain
por: Wu, Lin-xin, et al.
Publicado: (2021)

Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis
por: Lin, Chujiao, et al.
Publicado: (2019)

Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p
por: Xing, Zhiwei, et al.
Publicado: (2016)

Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer
por: Zhang, Ruitao, et al.
Publicado: (2021)

Circular RNA SMO sponges miR-338-3p to promote the growth of glioma by enhancing the expression of SMO
por: Xiong, Zhiyong, et al.
Publicado: (2019)

Toleration of Morphine
Publicado: (1880)

Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration
por: Yin, Liqian, et al.
Publicado: (2023)

Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer
por: Yong, Fung Lin, et al.
Publicado: (2013)

IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p
por: Zhang, Yunhong, et al.
Publicado: (2020)

MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B
por: Niu, Qin, et al.
Publicado: (2019)

Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis
por: Han, Bo, et al.
Publicado: (2017)

Hypoxia‐inhibited miR‐338‐3p suppresses breast cancer progression by directly targeting ZEB2
por: He, Juanjuan, et al.
Publicado: (2020)

miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer
por: Wei, Xiaoli, et al.
Publicado: (2021)

Effects of microRNA-223 on morphine analgesic tolerance by targeting NLRP3 in a rat model of neuropathic pain
por: Xie, Xiao-Juan, et al.
Publicado: (2017)

Sequential expression of miR-221-3p and miR-338-3p in Schwann cells as a therapeutic strategy to promote nerve regeneration and functional recovery
por: Wen, Li-Li, et al.
Publicado: (2022)

Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p
por: Zhang, Li, et al.
Publicado: (2019)

Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma
por: Zhou, Peng, et al.
Publicado: (2019)

LncRNA‐SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR‐338‐3p
por: Li, Min, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ptspmnkclilokk7jq44i9ijm9u